ERIN ROSIER: Open Payments
NPI 1790318160 · HELENA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,384 in 117 payments from 21 companies in 2025. Trend: 2023 $343 · 2024 $1,907 · 2025 $2,384
Food & beverage: $2,384
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $398 |
| ABBVIE INC. | 29 | $285 |
| AstraZeneca Pharmaceuticals LP | 12 | $213 |
| Axsome Therapeutics, Inc. | 9 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $192 |
| PFIZER INC. | 9 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $144 |
| SANOFI-AVENTIS U.S. LLC | 1 | $113 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| Astellas Pharma US Inc | 4 | $94 |
Products named: Kerendia, VRAYLAR, XIFAXAN, Rybelsus, Ozempic, TZIELD, Auvelity, Tryvio.
Industry payments across AL — which companies pay providers there.
